Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors

Cancer Immunology Immunotherapy ◽

10.1007/s00262-022-03141-4 ◽

2022 ◽

Author(s):

Yuhei Harutani ◽

Yuichi Ozawa ◽

Eriko Murakami ◽

Koichi Sato ◽

Jun Oyanagi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Serum Protein ◽

Clinical Benefit ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Protein Levels ◽

Download Full-text

Download PDF Package

Related Documents

Abstract 416: Predictive significance of serum protein levels in advanced non-small-cell lung cancer patients treated with pembrolizumab

10.1158/1538-7445.sabcs18-416 ◽

2019 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Shunsuke Teraoka ◽

Kuninobu Kanai ◽

Atsuhsi Hayata ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Serum Protein ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package

Abstract 416: Predictive significance of serum protein levels in advanced non-small-cell lung cancer patients treated with pembrolizumab

10.1158/1538-7445.am2019-416 ◽

2019 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Shunsuke Teraoka ◽

Kuninobu Kanai ◽

Atsuhsi Hayata ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Serum Protein ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package

Abstract 2608: Predictive values of serum protein levels in advanced non-small cell lung cancer patients treated with nivolumab

10.1158/1538-7445.am2018-2608 ◽

2018 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Hiroaki Akamatsu ◽

Kuninobu Kanai ◽

Atsushi Hayata ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Serum Protein ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Predictive Values ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package

Clinical Benefit of Chemotherapy for Small-Cell Lung Cancer Patients with Extremely Poor Performance Status (PS)

Annals of Cancer Research and Therapy ◽

10.4993/acrt.26.1 ◽

2018 ◽

Vol 26 (1) ◽

pp. 1-6

Author(s):

Ou Yamaguchi ◽

Hiroshi Kagamu ◽

Atsuto Mouri ◽

Ayako Shiono ◽

Harue Utsugi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Clinical Benefit ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Download PDF Package

Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients.

International Journal of Oncology ◽

10.3892/ijo.17.3.587 ◽

2000 ◽

Author(s):

A Cesano ◽

S R Lane ◽

G A Ross ◽

S Z Fields

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Clinical Benefit ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Download PDF Package

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Translational Lung Cancer Research ◽

10.21037/tlcr-20-359 ◽

2021 ◽

Vol 10 (1) ◽

pp. 274-278

Author(s):

Yusuke Tomita ◽

Bryan Oronsky ◽

Nacer Abrouk ◽

Pedro Cabrales ◽

Tony R. Reid ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Cell Lung Cancer ◽

Clinical Benefit ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Download PDF Package

Abstract 372: Association between pre-treatment biomarkers and survival in metastatic non-small cell lung cancer patients treated with first-line pembrolizumab

10.1158/1538-7445.am2021-372 ◽

2021 ◽

Author(s):

Ishani Joshi ◽

Monica Peravali ◽

Xue Geng ◽

Jiahua Zhang ◽

Giuseppe Giaccone ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package

Abstract A052: Detection of serum protein levels for predicting clinical benefit in advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors

10.1158/1535-7163.targ-19-a052 ◽

2019 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Hiroaki Akamatsu ◽

Koichi Sato ◽

Shunsuke Teraoka ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Clinical Benefit ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package

46P BASAL (PRE-TREATMENT) PET SCAN [MAXIMUM STANDARDIZED UPTAKE VALUES (SUVMAX)] AS A PROGNOSTIC FACTOR IN SMALL CELL LUNG CANCER PATIENTS WITH EXTENDED DISEASE

Lung Cancer ◽

10.1016/s0169-5002(13)70267-8 ◽

2013 ◽

Vol 80 ◽

pp. S20

Author(s):

S. Ponce Aix ◽

R. Manneh Kopp ◽

L. Parrilla Rubio ◽

L. Iglesias Docampo ◽

S. Ruiz Solis ◽

...

Keyword(s):

Lung Cancer ◽

Prognostic Factor ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Standardized Uptake Values ◽

Download Full-text

Download PDF Package

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/0360-3016(91)90099-p ◽

1991 ◽

Vol 20 (2) ◽

pp. 247-252 ◽

Author(s):

Philip Bonomi ◽

Meryl Gale ◽

Kendrith Rowland ◽

Samuel G. Taylor ◽

Sandra Purl ◽

...

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Combined Modality Treatment ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Download PDF Package